CORIS System

K253267 · Nanosonics Limited · SEW · Mar 5, 2026 · General Hospital

Device Facts

• Record ID: K253267
• Device Name: CORIS System
• Applicant: Nanosonics Limited
• Product Code: SEW · General Hospital
• Decision Date: Mar 5, 2026
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 880.6994
• Device Class: Class 2

Intended Use

The Nanosonics CORIS System is indicated for cleaning of the channels of compatible endoscopes. The CORIS System is suitable for use in healthcare facilities by trained healthcare personnel.

Device Story

Automated electromechanical device; cleans interior lumens, ports, and cylinders of reusable flexible endoscopes. Uses CORIS QUANTUM Cleaning Agent (dry powder hydrated to slurry); delivers agent in shots through endoscope channels. Cleaning mechanism: physical friction between cleaning agent particles and inner lumen surface; removes soil. System includes rinsing and air-purging cycles. Operated by trained healthcare personnel in healthcare facilities. Features color touch screen, integrated RFID for traceability, and self-disinfection cycle. Provides automated, verified, and traceable cleaning process; replaces manual cleaning. Output: cleaned endoscope channels. Benefits: standardized, reproducible cleaning; eliminates manual cleaning variability.

Clinical Evidence

No clinical data. Substantial equivalence supported by non-clinical bench testing, including simulated use cleaning validation, chemical residue analysis, material compatibility, software/cybersecurity verification, and human factors validation.

Technological Characteristics

Electromechanical automated endoscope channel cleaner. Materials: compatible with self-disinfection agents/wipe chemistries. Standards: IEC 62366-1, ISO 10993-1, ISO 14971, IEC 60601-1-2, IEC 61010-1, IEC 61010-2-040, IEC 62304, ISO 27001, ANSI/AAMI SW96. Connectivity: Ethernet port, 3 USB ports. User interface: color touch screen. Sterilization: self-disinfection cycle using Steris Revital-Ox Resert HLD. Software: firmware-controlled.

Indications for Use

Indicated for cleaning channels of compatible endoscopes in healthcare facilities by trained healthcare personnel.

Regulatory Classification

Identification

An automated endoscope channel cleaner is a device intended to replace all or a portion of manual cleaning of internal passages and ports of compatible, reusable flexible endoscopes. Cleaning is conducted using an agent that exerts physical force (e.g., friction) on single or multiple channels of compatible endoscopes for removal of soil. This device type is not intended to provide or replace high-level disinfection or sterilization.

Special Controls

In combination with the general controls of the FD&C Act, the automated endoscope channel cleaner is subject to the following special controls: (1) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use, including that the device meets all design specifications and performance requirements: (i) Design verification testing must ensure the device meets its specifications. (ii) Simulated use testing must evaluate device cleaning efficacy under worst-case simulated use conditions. (iii) In-use testing must evaluate device performance under clinical use conditions. (iv) Evaluation of cleaning agent residues must include: (A) Quantitation of residues in compatible endoscope channels and ports; (B) Analysis of the impact of device use on subsequent reprocessing steps, such as high-level disinfection and sterilization; and (C) Evaluation of impact of device use on endoscope biocompatibility. (v) Compatibility testing of the device with compatible endoscope(s) must be conducted, to include a life cycle assessment study. The labeled life cycle must not exceed the endoscope manufacturer's life cycle specification. (vi) Cleaning agent shelf-life testing must demonstrate continued performance of the cleaning agent over its labeled shelf life. (2) Performance testing must demonstrate electromagnetic compatibility and electrical and mechanical safety of the device in the intended use environment. (3) Software verification, validation, and hazard analysis must be performed for any software components of the device. (4) Human factors testing must demonstrate that an intended user can correctly use the device for its intended use, based solely on its labeling and instructions for use. (5) Labeling must include the following: (i) A detailed summary of the device technical parameters, including any specifications; (ii) A statement regarding user adherence to the endoscope manufacturer's recommendations for use and cleaning of external/incompatible surfaces, as well as adherence to the manufacturer's validated microbicidal process for the entire device, drying and storage conditions; and (iii) Instructions for disinfection and maintenance of the automated endoscope channel cleaner.

Predicate Devices

• CORIS System (DEN240018)

Submission Summary (Full Text)

{0}

FDA

U.S. FOOD & DRUG

ADMINISTRATION

March 5, 2026

Nanosonics Limited
Nancy Kaiser
Regulatory Affairs Manager
7-11 Talavera Road
Macquarie Park, NSW 2113
Australia

Re: K253267
Trade/Device Name: CORIS System
Regulation Number: 21 CFR 880.6994
Regulation Name: Automated endoscope channel cleaner
Regulatory Class: Class II
Product Code: SEW
Dated: September 29, 2025
Received: January 30, 2026

Dear Nancy Kaiser:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}

K253267 - Nancy Kaiser
Page 2

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).

Your device is also subject to, among other requirements, the Quality Management System Regulation (QMSR) (21 CFR Part 820), which includes, but is not limited to, ISO 13485 clause 7.3 (Design controls), ISO 13484 clause 8.3 (Nonconforming product), and ISO 13485 clause 8.5 (Corrective and preventative action). Please note that regardless of whether a change requires premarket review, the QMSR requires device manufacturers to review and approve changes to device design and production (ISO 13485 clause 7.3 and 21 CFR 820.70) and document changes and approvals in the Medical Device File (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the Quality Management System Regulation (QMSR) (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-

{2}

K253267 - Nancy Kaiser
Page 3

assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,


For Katharine Segars
Assistant Director
DHT4C: Division of Infection Control Devices
OHT4: Office of Surgical and Infection Control Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health

Enclosure

{3}

FORM FDA 3881 (8/23)
Page 1 of 1
PSC Publishing Services [phone]
EF

| DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Indications for Use | Form Approved: OMB No. 0910-0120 Expiration Date: 07/31/2026 See PRA Statement below. |
| --- | --- |
| 510(k) Number (if known) K253267 | |
| Device Name CORIS System | |
| Indications for Use (Describe) | |
| The Nanosonics CORIS System is indicated for cleaning of the channels of compatible endoscopes. The CORIS System is suitable for use in healthcare facilities by trained healthcare personnel. | |
| Type of Use (Select one or both, as applicable) ☐ Prescription Use (Part 21 CFR 801 Subpart D) ☑ Over-The-Counter Use (21 CFR 801 Subpart C) | |
| CONTINUE ON A SEPARATE PAGE IF NEEDED. | |
| This section applies only to requirements of the Paperwork Reduction Act of 1995. *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* | |
| The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail] | |
| "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." | |

{4}

nanosonics

510(k) SUMMARY - CORIS System

# I. DATE PREPARED

March 4, 2026

# II. 510(k) NUMBER

K253267

# III. 510(k) SUBMITTER

Nanosonics Limited

7-11 Talavera Road

Macquarie Park NSW 2113

Australia

Contact Person: Nancy Kaiser,

Regulatory Affairs Manager

Address: 7-11 Talavera Road

Macquarie Park, NSW 2113

Australia

Email: [e-mail]

Telephone: [phone]

# IV. DEVICE

Trade Name of Device: CORIS System

Common or Usual Name: Automated Endoscope Channel Cleaner

Classification: II

Regulation Number: 21 CFR 880.6994

Product Code: SEW

# V. PREDICATE DEVICE

## Predicate Device

Trade Name: CORIS System

De Novo Classification

Number: DEN240018

Company Name: Nanosonics Ltd.

# VI. DEVICE DESCRIPTION

The CORIS System is an automated electromechanical device which utilizes the CORIS QUANTUM Cleaning Agent to clean endoscope channels (including interior of the lumens, ports, and cylinders) of validated and compatible reusable flexible endoscopes. The CORIS QUANTUM Cleaning Agent is provided as a dry powder, which upon installation is hydrated to create a slurry. During the cleaning cycle, the CORIS System delivers the cleaning agent providing physical cleaning to all endoscope channels. The endoscope channels are then rinsed and purged with air. The CORIS System is intended for over-the-counter use by healthcare personnel.

{5}

nanosonics
Mention Prevention The Life

# VII. INDICATIONS FOR USE

The Nanosomics CORIS System is indicated for cleaning of the channels of compatible endoscopes.

The CORIS System is suitable for use in healthcare facilities by trained healthcare personnel.

# VIII. COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH THE PREDICATE DEVICE

The CORIS System with proposed modifications is as safe and effective in terms of technological characteristics and principles of operation to the predicate device, CORIS System.

The subject device, CORIS System shares the same fundamental technological characteristics as the predicate device. Both devices are automated endoscope channel cleaners that utilize the CORIS QUANTUM Cleaning Agent to clean the lumen of the endoscope. The cleaning process relies on physical friction generated as the Cleaning Agent particles pass through both the small and large channels of the endoscope. The Cleaning Agent is delivered in shots, and as the particles move through the channels, the physical action of friction between the particles and the inner surface of the lumen effectively removes soils from the endoscope.

The design, materials and mode of operation are substantially equivalent to the predicate device, with no significant differences that raise new question of safety or effectiveness. Any differences between the subject device and the predicate device have been evaluated through successful verification and validation testing using parameters equivalent as those applied to the predicate device. These evaluations confirm that the differences do not raise new questions of safety or effectiveness.

Page 2 of 12

{6}

nanosonics

Table 1. A Comparison between the Subject and Predicate Device

| Feature | Subject Device: CORIS System | Predicate Device: CORIS System (DEN240018) | Comparison |
| --- | --- | --- | --- |
| Manufacturer | Nanosonics Limited | Nanosonics Limited | Same |
| Regulation Number | 21 CFR 880.6994 | 21 CFR 880.6994 | Same |
| Product Code | SEW | SEW | Same |
| Intended Use | The Nanosonics CORIS System is intended to clean the channels of endoscopes, when used in accordance with its labelling. The CORIS System is an electromechanical system that replaces manual cleaning of endoscope channels with an automated, verified and traceable cleaning process. Manual cleaning of endoscope channels is not required prior to cleaning with the CORIS System. | The Nanosonics CORIS System is intended to clean the channels of endoscopes, when used in accordance with its labelling. The CORIS System is an electromechanical system that replaces manual cleaning of endoscope channels with an automated, verified and traceable cleaning process. Manual cleaning of endoscope channels is not required prior to cleaning with the CORIS System. | Same |
| Indication for Use | The Nanosonics CORIS System is indicated for cleaning of the channels of compatible endoscopes.The CORIS System is suitable for use in healthcare facilities by trained healthcare personnel. | The Nanosonics CORIS System is indicated for cleaning of the channels of the Olympus EVIS EXERA III CF-HQ190L colonovideoscope.The CORIS System is suitable for use in healthcare facilities by trained healthcare workers. | Substantially Equivalent based on V&V testing. |
| Operating Principle | Software controlled system that uses the CORIS QUANTUM Cleaning Agent to clean the lumen of the endoscope through physical friction created as the cleaning agent particles pass through the small and large channels of the endoscope. The shots of Cleaning Agent travel through the channels and the physical action created through friction of these particles and the inner surface of the lumen, is what removes soil from the endoscope. | Software controlled system that uses the CORIS QUANTUM Cleaning Agent to clean the lumen of the endoscope through physical friction created as the cleaning agent particles pass through the small and large channels of the endoscope. The shots of Cleaning Agent travel through the channels and the physical action created through friction of these particles and the inner surface of the lumen, is what removes soil from the endoscope. | Same |
| Cleaning Agent | CORIS QUANTUM | CORIS QUANTUM | Same |
| Cleaning Agent Open Bottle Shelf Life | 5 days | 1day | Substantially Equivalent based on V&V testing |
| Cleaning Agent Shelf Life | 7 months | 6 months | Substantially Equivalent |

{7}

nanosonics

| | | | based on V&V testing |
| --- | --- | --- | --- |
| Device Performance Standards | IEC 62366 -1ISO 10993-1ISO 14971IEC 60601-4-2:2024ISO 10993-1ISO 14971IEC 60601-1-2 Edition 4.12020-09 Consolidated VersionIEC 61010-1 Edition 3.12017-01 Consolidated VersionIEC 61010-2-040:2020IEC62304:2006+AMD1:2015ISO 27001:2002ANSI/AAMI SW96:2023AAMI/ANSI/IEC TIR80001-2-2:2012 | ISO 62366 -1 and -2ISO 10993-1ISO 14971IEC 60601-4-2:2024ISO 10993-1ISO 14971IEC 60601-1-2 Edition 4.12020-09 Consolidated VersionIEC 61010-1 Edition 3.12017-01 Consolidated VersionIEC 61010-2-040:2020IEC62304:2006+AMD1:2015ISO 27001:2002ANSI/AAMI SW96:2023AAMI/ANSI/IEC TIR80001-2-2:2012 | Same |
| Cleaning Agent Residue Testing | Meets the recommendationsFDA Guidance “Medical Washers and Medical Washer-Disinfectors - Class II Special Controls Guidance Document for the Medical Device Industry and FDA Review Staff” February 7, 2002 , FDA Guidance “Guidance on Premarket Notification [510(k)]Submissions for Automated Endoscope Washers, Washer/Disinfectors, and Disinfectors Intended for Use in Health Care Facilities” August 1993 and FDA Guidance “Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling”March 17, 2015 | Meets the recommendationsFDA Guidance “Medical Washers and Medical Washer-Disinfectors - Class II Special Controls Guidance Document for the Medical Device Industry and FDA Review Staff” February 7, 2002 , FDA Guidance “Guidance on Premarket Notification [510(k)]Submissions for Automated Endoscope Washers, Washer/Disinfectors, and Disinfectors Intended for Use in Health Care Facilities” August 1993 and FDA Guidance “Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling”March 17, 2015 | Same |
| Touch Screen | Color touch screen panel | Color touch screen panel | Same |
| Software/Firmware Control | Yes | Yes | Same |
| Contains Self-Disinfection Cycle | Yes | Yes | Same |
| Traceability | An integrated RFID module allowing automated traceability features in the device.Patient information is not received or recorded by the device; therefore, it cannot | An integrated RFID module allowing automated traceability features in the device.Patient information is not received or recorded by the | Same |

{8}

nanosonics

Machine Prevention for Life

# IX. SUMMARY OF NON-CLINICAL TESTING

In support of the substantial equivalence determination, the following non-clinical tests were performed:

Table 2. Summary of Non-clinical Testing

| Test | Brief Description | Applicable Standard | Acceptance Criteria | Results (Pass/Fail) |
| --- | --- | --- | --- | --- |
| System Life Testing and Endoscope Compatibility | Back-to-back Cleaning and Self Disinfection cycles to assess CORIS System lifetime. | N/A | CORIS System Function - At the end of test, the CORIS device shall still be fit for its intended purpose. Endoscope Function - At the end of the test, the endoscope under test shall still be fit for its intended purpose Installation Accessories Function (Wall Mount, Surface Mount, PSU Bracket) - At the end of the test, the installation accessory under test should show no signs of corrosion or rusting, bending and/or distortion. Multi-dose Cleaning Consumable Capacity - For all completed | Pass |
| | be accessed via RFID. | device; therefore, it cannot be accessed via RFID. | | |
| Communication Ports | 3 USB ports for connecting external devices 1 Ethernet port The CORIS Device supports external network connection through the integrated Ethernet port. | 3 USB ports to connect to external devices 1 Ethernet port The CORIS Device supports external network connection through the integrated Ethernet port. | Same | |
| Key Accessories | CORIS QUANTUM CORIS Adaptor CORIS Smart Drain CORIS Smart Drain Adaptor CORIS Smart Drain Seal CORIS Maintenance Kit Flushing Accessory | CORIS QUANTUM CORIS Adaptor CORIS Splash Guard CORIS Splash Guard Tube CORIS Splash Guard Seal CORIS Self-Disinfection Kit CORIS Lens Cover and Lens Cover Aid | Substantially Equivalent based on V&V testing | |
| Self-Disinfection Disinfectant | Steris Revital-Ox Resert High Level Disinfectant | Steris Revital-Ox Resert High Level Disinfectant | Same | |

{9}

nanosonics

Member Prevention for Life

| | | | bottle, CORIS Cleaning Consumable should last for at least the minimum required number of cycles | |
| --- | --- | --- | --- | --- |
| CORIS Cleaning Validation - Simulated Use Test | Simulated use testing was conducted under worst case conditions per the FDA Guidance “Medical Washers and Medical Washer-Disinfectors - Class II Special Controls Guidance Document for the Medical Device Industry and FDA Review Staff” February 7, 2002 and “Guidance on Premarket Notification [510(k)] Submissions for Automated Endoscope Washers, Washer/Disinfectors, and Disinfectors Intended for Use in Health Care Facilities” August 1993 and FDA Guidance “Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling” March 17, 2015 | ANSI/AAMI ST98:2022 (Same test methods and acceptance criteria as DEN240018) | Meets standard and recommendations of Section II.I.3.c of FDA Guidance “Medical Washers and Medical Washer-Disinfectors - Class II Special Controls Guidance Document for the Medical Device Industry and FDA Review Staff” February 7, 2002 | Pass |
| Error Handling | The test was to verify the CORIS System’s ability to detect error conditions. | N/A | All expected results shall be met. | Pass |
| User Interface | The test was conducted to verify that the CORIS System appropriately generates and sends notifications to the user regarding errors and other critical process events. | N/A | All expected results shall be met. | Pass |
| Transportation - CORIS Chassis/Body | Simulated transportation testing performed to ensure that packaging and device will not be compromised during shipping. | ASTM D4169-22 | Meets standard. | Pass |
| Transportation - CORIS Engine | Simulated transportation testing performed to ensure that packaging and device will not be compromised during shipping. | ASTM D4169-22 | Meets standard. | Pass |
| Transportation – QUANTUM Cleaning Agent | Simulated transportation testing performed to ensure that packaging and device will not be | ASTM D4169-22 | Meets standard | Pass |

Page 6 of 12

{10}

nanosonics

| | compromised during shipping. | | | |
| --- | --- | --- | --- | --- |
| Transportation - CORIS Accessories | Simulated transportation testing performed to ensure that packaging and device will not be compromised during shipping. | ASTM D4169-22 | Meets standard | Pass |
| Chemistry - CORIS Quantum Open Shelf-life | The test was to assess product stability after the cleaning agent container is opened | Q1A(R2) Stability Testing of New Drug Substances and Products | Meets the recommendations of Q1A(R2) Stability Testing of New Drug Substances and Products | Pass |
| Chemistry - QUANTUM Analysis in an Endoscope After CORIS Cleaning | The test was to evaluate the chemical residues remaining in an endoscope following cleaning with the CORIS System. | N/A (Same test methods and acceptance criteria as DEN240018) | Meets the recommendations of Section II.I.3.e of “Medical Washers and Medical Washer-Disinfectors - Class II Special Controls Guidance Document for the Medical Device Industry and FDA Review Staff” February 7, 2002 and Section II.G.2.c.(3) of “Guidance on Premarket Notification [510(k)] Submissions for Automated Endoscope Washers, Washer/Disinfectors, and Disinfectors Intended for Use in Health Care Facilities” August 1993 and Section II.C. Criterion 5.F, and Section VI of “Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling” March 17, 2015 | Pass |
| Materials Compatibility for CORIS System | The test was to evaluate the compatibility of the applicable CORIS device parts and its accessories with self-disinfection agents and wipe chemistries. | ASTM F1980-21 ASTM D543-21 | Meets standards and recommendations of Section II.F.3 of “Medical Washers and Medical Washer-Disinfectors - Class II Special Controls Guidance Document for the Medical Device Industry and FDA Review Staff” February 7, 2002 and Section II.C.3 of “Guidance on Premarket Notification [510(k)] Submissions for Automated | Pass |

Page 7 of 12

{11}

nanosonics

Member Prevention for Life

| | | | Endoscope Washers, Washer/Disinfectors, and Disinfectors Intended for Use in Health Care Facilities” August 1993 | |
| --- | --- | --- | --- | --- |
| CORIS Exterior Device Reprocessing | Test was performed per FDA Guidance “Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling” March 17, 2015 | ISO 17664-2:2021
ANSI/AAMI ST98:2022
ASTM E2362-22
ASTM E1837-96
AAMI TIR12:2020

(Same test methods and acceptance criteria as DEN240018) | Meets standards. | Pass |
| Smart Drain Reprocessing | Test was performed per FDA Guidance “Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling” March 17, 2015 | ISO 17664-2:2021
ANSI/AAMI ST98:2022
ASTM E2362-22
ASTM E1837-96
AAMI TIR12:2020

(Same test methods and acceptance criteria as DEN240018) | Meets standards. | Pass |
| Adaptor Reprocessing | The test was conducted per FDA Guidance “Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling” March 17, 2015 and FDA Guidance “Content and Format of Premarket Notification [510(k)] Submissions for Liquid Chemical Sterilants/ High Level Disinfectants” January 3, 2000 | ISO 17664-2:2021
ANSI/AAMI ST98:2022
ASTM E2362-22
ASTM E1837-96
AOAC 965.12
AAMI TIR12:2020

(Same test methods and acceptance criteria as DEN240018) | Meets standards and the recommendations of Section III.H.5.b of Content and Format Premarket Notification [510(k)] Submission for Liquid Chemical Sterilants/ High Level Disinfectants” January 3, 2000 | Pass |
| Smart Drain Adaptor Reprocessing | The test was conducted per FDA Guidance “Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling” March 17, 2015 and FDA Guidance “Content and Format of Premarket Notification [510(k)] Submissions for Liquid Chemical Sterilants/ High Level Disinfectants” January 3, 2000 | ISO 17664-2:2021
ANSI/AAMI ST98:2022
ASTM E2362-22
ASTM E1837-96
AOAC 965.12
AAMI TIR12:2020

(Same test methods and acceptance criteria as DEN240018) | Meets standards and the recommendations of Section III.H.5.b of Content and Format Premarket Notification [510(k)] Submission for Liquid Chemical Sterilants/ High Level Disinfectants” January 3, 2000 | Pass |
| Maintenance Kit Reprocessing | The test was conducted per FDA Guidance “Reprocessing Medical Devices in Health Care | ISO 17664-2:2021
ANSI/AAMI ST98:2022
ASTM E2362-22
ASTM E1837-96 | Meets standards and the recommendations and Section III.H.5.b of Content and Format | Pass |

Page 8 of 12

{12}

nanosonics

Member Prevention for Life

| | Settings: Validation Methods and Labeling” March 17, 2015 and FDA Guidance “Content and Format of Premarket Notification [510(k)] Submissions for Liquid Chemical Sterilants/ High Level Disinfectants” January 3, 2000 | AOAC 965.12 AAMI TIR12:2020 (Same test methods and acceptance criteria as DEN240018) | Premarket Notification [510(k)] Submission for Liquid Chemical Sterilants/ High Level Disinfectants” January 3, 2000 | |
| --- | --- | --- | --- | --- |
| Flushing Accessory Reprocessing | The test was conducted per FDA Guidance “Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling” March 17, 2015 and FDA Guidance “Content and Format of Premarket Notification [510(k)] Submissions for Liquid Chemical Sterilants/ High Level Disinfectants” January 3, 2000 | ISO 17664-2:2021 ANSI/AAMI ST98:2022 ASTM E2362-22 ASTM E1837-96 AOAC 965.12 AAMI TIR12:2020 (Same test methods and acceptance criteria as DEN240018) | Meets standards and the recommendations per Section III.H.5.b of "Content and Format Premarket Notification [510(k)] Submission for Liquid Chemical Sterilants/ High Level Disinfectants" January 3, 2000 | Pass |
| Self-Disinfection Interval | Test was performed per the FDA Guidance “Medical Washers and Medical Washer-Disinfectors - Class II Special Controls Guidance Document for the Medical Device Industry and FDA Review Staff” February 7, 2002 | N/A (Same test methods and acceptance criteria as DEN240018) | Meets the recommendations of Section II.I.3.f of “Medical Washers and Medical Washer-Disinfectors - Class II Special Controls Guidance Document for the Medical Device Industry and FDA Review Staff” February 7, 2002 | Pass |
| Self-Disinfection HLD Efficacy | Test was performed per the FDA Guidance “Medical Washers and Medical Washer-Disinfectors - Class II Special Controls Guidance Document for the Medical Device Industry and FDA Review Staff” February 7, 2002 and FDA Guidance “Content and Format of Premarket Notification [510(k)] Submissions for Liquid Chemical Sterilants/ High Level Disinfectants” January 3, 2000 | AAMI TIR12:2020 (Same test methods and acceptance criteria as DEN240018) | Meets the recommendations of Section III.H.5.b of "Content and Format Premarket Notification [510(k)] Submission for Liquid Chemical Sterilants/ High Level Disinfectants" January 3, 2000 | Pass |

Page 9 of 12

{13}

nanosonics

| Self-Disinfection Use Conditions Test | Test was performed per the FDA Guidance “Medical Washers and Medical Washer-Disinfectors - Class II Special Controls Guidance Document for the Medical Device Industry and FDA Review Staff” February 7, 2002 and FDA Guidance “Guidance on Premarket Notification [510(k)] Submissions for Automated Endoscope Washers, Washer/Disinfectors, and Disinfectors Intended for Use in Health Care Facilities” August 1993 | AAMI TIR12:2020 | Meets the recommendations of Section II.I.3.f of “Medical Washers and Medical Washer-Disinfectors - Class II Special Controls Guidance Document for the Medical Device Industry and FDA Review Staff” February 7, 2002 and Section II.G.2.c of “Guidance on Premarket Notification [510(k)] Submissions for Automated Endoscope Washers, Washer/Disinfectors, and Disinfectors Intended for Use in Health Care Facilities” August 1993 | Pass |
| --- | --- | --- | --- | --- |
| Impact of Downstream Reprocessing | Test was performed per FDA Guidance “Content and Format of Premarket Notification [510(k)] Submissions for Liquid Chemical Sterilants/ High Level Disinfectants” January 3, 2000 | N/A (Same test methods and acceptance criteria as DEN240018) | Meets the recommendations of Section III.H.5.a of “Content and Format of Premarket Notification [510(k)] Submissions for Liquid Chemical Sterilants/ High Level Disinfectants” January 3, 2000 | Pass |
| Cleaning Agent Residues for Biocompatibility | The test was performed to evaluate cleaning agent residues remaining on an endoscope after cleaning with the CORIS System. | N/A (Same test methods and acceptance criteria as DEN240018) | Meets the recommendations of Section II.J of “Medical Washers and Medical Washer-Disinfectors - Class II Special Controls Guidance Document for the Medical Device Industry and FDA Review Staff” February 7, 2002 and Section II.I of “Guidance on Premarket Notification [510(k)] Submissions for Automated Endoscope Washers, Washer/Disinfectors, and Disinfectors Intended for Use in Health Care Facilities” August 1993 and Section VI of “Reprocessing Medical | Pass |

{14}

nanosonics

Member Prevention for Life

| | | | Devices in Health Care Settings: Validation Methods and Labeling” March 17, 2015 | |
| --- | --- | --- | --- | --- |
| Software and Cybersecurity | The software testing was conducted as per FDA guidance document “Content of Premarket Submissions for Device Software Functions” issued June 14, 2023
Cybersecurity testing was conducted per FDA guidance documents, “Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions” issued June 27, 2025 | N/A
(Same acceptance criteria as DEN240018) | Meets the recommendations of FDA guidance document “Content of Premarket Submissions for Device Software Functions” issued June 14, 2023 and FDA guidance document “Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions” issued June 27, 2025 | Pass |
| Electromagnetic Compatibility and Electrical Safety | Electromagnetic Compatibility (EMC) of the CORIS device has been evaluated in accordance with IEC 60601-1-2, Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral Standard: Electromagnetic disturbances - Requirements and tests.
Electrical safety testing of the CORIS device was completed in accordance with IEC 61010-1, Safety requirement for electrical equipment for measurement, control and laboratory use. Part 1: General requirements and IEC 61010-2-040, Safety requirements for electrical equipment for measurement, control and laboratory use. Part 2-040: Particular requirement for sterilizers and washer-disinfectors used to treat medical materials. | IEC 60601-1-2
IEC 61010-1
IEC 61010-2-040 | Meets standards | Pass |
| Human Factors | Human factors validation testing of the CORIS System was conducted per FDA Guidance " Applying Human Factors | | | |

Page 11 of 12

{15}

nanosonics

Advances For Life

| | and Usability Engineering to Medical Devices" issued February 3, 2016. | | | |
| --- | --- | --- | --- | --- |

# X. CLINICAL TESTING

N/A

# XI. CONCLUSION

Based on the intended use, technological characteristics, and conclusions drawn from the non-clinical tests, proposed device is determined to be Substantially Equivalent (SE) to predicate device granted under DEN240018.